Pirenoxine (Kary Uni) 50 mcg/mL ophthalmic suspension is an orange, sterile, aqeous ophthalmic suspension containing 50 mcg of pirenoxine as an active ingredient in each mL. Excipients/Inactive Ingredients: It also contains disodium edetate hydrate, benzalkonium chloride, concentrated glycerin and polyoxyethylene hydrogenated castor oil 60 as additives.
Action
Its pH is between 3.4 and 4.0 and the osmolar ratio is between 0.9 and 1.2. Immediately after topical application, the pH of this preparation becomes equivalent to that of the lacrimal fluid, the suspended pirenoxine particles being dissolved in the lacrimal fluid.
Indications/Uses
Incipient senile cataract.
Dosage/Direction for Use
Shake well before use, and instill 1 or 2 drops a time, 3 to 5 times daily.
Special Precautions
Route of administration: Ophthalmic use only.
The tip of the eyedropper must not come into contact with the eyes at the time of application.
This product is discolored after contamination with metal ions.
Since particles in the suspension may not disperse depending on storage conditions even after well shaking, store the product in an upright position.
Adverse Reactions
Rarely: <0.1%, infrequently: 0.1%-<5%, no specific designation: ≥5% or frequency unknown.
Blepharitis, contact dermatitis, and other symptoms of hypersensitivity may occur. When such symptoms occur, discontinue the use.
Diffuse superficial keratitis, conjunctival injection, irritation, itching, etc. may occur. When such symptoms occur, discontinue the use.
Sign Out
